{
    "clinical_study": {
        "@rank": "105804", 
        "arm_group": {
            "arm_group_label": "T.R.U.E. Test Panel 3.2", 
            "arm_group_type": "Experimental", 
            "description": "T.R.U.E. Test Panel allergens; Gold sodium thiosulfate, Hydrocortisone-17-butyrate, Bacitracin, Parthenolide, Methyldibromoglutaronitrile, Disperse blue 106, and Bronopol"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the performance and safety of seven T.R.U.E. Test Panel allergens in subjects\n      6-17 years of age with suspected contact dermatitis."
        }, 
        "brief_title": "Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Allergic Contact Dermatitis", 
        "condition_browse": {
            "mesh_term": [
                "Dermatitis", 
                "Dermatitis, Contact", 
                "Dermatitis, Allergic Contact"
            ]
        }, 
        "detailed_description": {
            "textblock": "To evaluate the diagnostic performance (primary) and safety (secondary) of seven T.R.U.E.\n      Test Panel allergens; Gold sodium thiosulfate, Hydrocortisone-17-butyrate, Bacitracin,\n      Parthenolide, Methyldibromoglutaronitrile, Disperse blue 106, and Bronopol in pediatric\n      subjects 6-17 years of age with suspected contact dermatitis based on symptoms and clinical\n      history."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Symptoms and history potentially consistent with allergic contact dermatitis\n\n          -  Children and adolescents 6-17 years of age, in general good health\n\n          -  Adolescent females 15 years of age or older (or with menarche) must consent to a\n             urine pregnancy test; urine test results must be negative for study inclusion\n\n          -  Informed consent must be signed and understood by subject.  If underage, informed\n             consent must be signed and understood by parent or legal guardian, consistent with\n             all institutional, local and national regulations\n\n        Exclusion Criteria:\n\n          -  Topical corticosteroid treatment during the last 7 days on or near the test area.\n\n          -  Systemic treatment with corticosteroids or other immunosuppressives during the last 7\n             days.\n\n          -  Subjects currently receiving (or received during the previous 3 weeks) other\n             investigational drugs, treatments or devices, or participating in another clinical\n             study\n\n          -  Treatment with ultraviolet (UV) light (including tanning) during the previous 3 weeks\n\n          -  Acute dermatitis outbreak or dermatitis on or near the test area on the back\n\n          -  Subjects unable to comply with activity restrictions (e.g. protecting test panels\n             from excess moisture due to showering or vigorous activity)\n\n          -  Subjects unable or unwilling to comply with multiple return visits\n\n          -  Female subjects 15 years of age (or with onset of menarche) and older unable to\n             consent to a urine pregnancy test, or those with a positive pregnancy test"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01797562", 
            "org_study_id": "SP 12 7NEW 401"
        }, 
        "intervention": {
            "arm_group_label": "T.R.U.E. Test Panel 3.2", 
            "description": "Surgical tape containing 12 polyester allergen patches.", 
            "intervention_name": "T.R.U.E. Test Panel 3.2", 
            "intervention_type": "Drug", 
            "other_name": [
                "Gold sodium thiosulfate", 
                "Hydrocortisone-17-butyrate", 
                "Bacitracin", 
                "Parthenolide", 
                "Methyldibromoglutaronitrile", 
                "Disperse blue 106", 
                "Bronopol"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Bacitracin", 
                "Bronopol", 
                "Sodium thiosulfate", 
                "Cortisol succinate", 
                "Hydrocortisone acetate", 
                "Hydrocortisone 17-butyrate 21-propionate", 
                "Parthenolide", 
                "Hydrocortisone", 
                "Hydrocortisone-17-butyrate", 
                "Gold Sodium Thiosulfate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Contact dermatitis", 
            "Eczema"
        ], 
        "lastchanged_date": "December 17, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Ann Funk, RN", 
                    "phone": "858-576-1700", 
                    "phone_ext": "4295"
                }, 
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92123"
                    }, 
                    "name": "Rady Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "Lawrence Eichenfield, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Teresa Derian, RN", 
                    "phone": "303-724-9155"
                }, 
                "facility": {
                    "address": {
                        "city": "Aurora", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80045"
                    }, 
                    "name": "Anschutz Health and Wellness Center, University of Colorado"
                }, 
                "investigator": {
                    "last_name": "Cory Dunnick, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maureen Beyel, RN", 
                    "phone": "502-582-7546"
                }, 
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40202"
                    }, 
                    "name": "Dermatology Specialists"
                }, 
                "investigator": {
                    "last_name": "Joseph Fowler, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Kristin Morton", 
                    "phone": "503-494-4662"
                }, 
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97239"
                    }, 
                    "name": "Oregon Health & Science University"
                }, 
                "investigator": {
                    "last_name": "Patricia Norris, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical Evaluation of T.R.U.E. Test Panel 3.2 in Children and Adolescents (PREA II)", 
        "overall_contact": {
            "last_name": "Kim Sullivan", 
            "phone": "602-225-0595"
        }, 
        "overall_official": [
            {
                "affiliation": "Anschutz Health and Wellness Center, University of Colorado, Aurora, CO", 
                "last_name": "Cory Dunnick, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Dermatology Specialists, Louisville, KY", 
                "last_name": "Joseph Fowler, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Rady Children's Hospital, San Diego", 
                "last_name": "Lawrence Eichenfield, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Oregon Health and Science University", 
                "last_name": "Patricia Norris, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Frequency and characterization of positive reactions per allergen.", 
            "safety_issue": "No", 
            "time_frame": "Day 21"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01797562"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Prevalence of late or persistent reactions, irritation, adhesion, subject-reported itching or burning, and adverse events.", 
            "safety_issue": "Yes", 
            "time_frame": "Day 21"
        }, 
        "source": "Allerderm", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allerderm", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}